Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. (Q34602613)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. |
scientific article |
Statements
Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate (English)
Uta B Hofmann
Claudia S Kauczok-Vetter
1 January 2009